Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dynamics of oligodendrocyte generation and myelination in the human brain.
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels.
Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.
A single session of 1 mA anodal tDCS-supported motor training does not improve motor performance in patients with multiple sclerosis.
Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma.
Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.
GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
Prognostic Factors of MS Conversion in Optic Neuritis.
Rituximab combination therapy in relapsing multiple sclerosis.
Multiple Sclerosis (MS) as a demyelinating disease: a review on neurosurgical approaches.
Tongue Somatosensory-Evoked Potentials: Evaluation of the Afferent Trigeminal Pathway in Patients With Early Multiple Sclerosis.
A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity.
Endovascular diagnosis and management of chronic cerebrospinal venous insufficiency: retrospective analysis of 30-day morbidity and mortality in 95 consecutive patients.
The use of interferon Beta and glatiramer acetate in multiple sclerosis.
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Acute Disseminated Encephalomyelitis in a Child Following Plasmodium vivax Malaria.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Transglutaminase 2 and neuroinflammation.
cFLIP is critical for oligodendrocyte protection from inflammation.
[Current description of multiple sclerosis].
Pages
« first
‹ previous
…
359
360
361
362
363
364
365
366
367
…
next ›
last »